Clinical efficacy, safety and biomarker exploration of RET-TKIs in Chinese RET fusion-positive NSCLC: a multicenter real-world analysis

Clinical Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles